Completed PHASE3 INTERVENTIONAL 2-arm NCT00000569

Lung Health Study II (LHSII)

The Chronic Obstructive Pulmonary Disease Early Intervention Trial

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Chronic Obstructive Pulmonary Disease Lung Diseases Lung Diseases, Obstructive

Updated 8 times since 2017 Last updated: Oct 30, 2019 Started: Sep 30, 1993 Primary completion: May 31, 1999 Completion: May 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000569, this PHASE3 trial focuses on Chronic Obstructive Pulmonary Disease and Lung Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 8 times since 1993, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Dec 2019 — Jan 2021 [monthly]

Completed PHASE3
Nov 2019 — Dec 2019 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Nov 2019 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Sep 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.